Once we decide on a strategy, we consider grants that will support it. We look for partners who can carry out our strategy. We generally make three- to five-year grants and establish formal agreements with expected outcomes.
Most of our grantmaking goes to large intermediary partners—organizations that in turn provide funding and support to those doing the work in the field. This lets us take advantage of expertise that others already have, and it builds up expertise among people in the field rather than simply on our staff. In our United States Program, for example, we make grants to charter management organizations, which use the funds to support groups that are creating new schools.
Examples:
HIV Vaccine Development - Global Health Program We made a grant in July 2006 to create the Collaboration for AIDS Vaccine Discovery (CAVD) a global network of research teams. This collaborative effort has grown to 200 investigators from 22 countries who work to apply new technologies, concepts and approaches to the design of safe and effective preventive vaccines against HIV/AIDS. CAVD now includes 14 vaccine discovery consortia and five central service facilities enabling investigators to openly share data and compare results. This allows researchers to quickly prioritize the most promising vaccine approaches for further development.
Learn more about our grant to CAVD.
Learn more about our work with HIV/AIDS.
Malaria Strategy - Global Health Program
Working with experts and partners, members of our Global Health team crafted an approach to help fight malaria, identifying key gaps in malaria efforts and outlining the cost. The Global Health team presented a malaria strategy to Bill, Melinda, and former CEO Patty Stonesifer in 2004. Once it had been approved, the team moved on to the next step: making grants that were consistent with that strategy. In 2007, an even more ambitious strategy was presented and approved.
Learn more about our work with Malaria.
Previous | Next: Measure Progress